Prokaryotic vs Eukaryotic Cells

Core Explanation

The core difference: the nucleus. Recall from A&P I that cells come in two fundamental types:

• Prokaryotic cells (pro = before, karyon = nucleus) have no true nucleus and no membrane-bound organelles. Their DNA sits freely in the cytoplasm (in a region called the nucleoid). Bacteria and archaea are prokaryotes.
• Eukaryotic cells (eu = true) have a true, membrane-bound nucleus and membrane-bound organelles (like mitochondria, ER, Golgi — recall organelles). Fungi, protozoa, plants, and animals (including humans) are eukaryotes.

This single difference — the presence or absence of a nucleus and organelles — is the foundation of cell classification.

Other key differences. Beyond the nucleus, prokaryotes and eukaryotes differ in ways that matter for microbiology:

• Size: prokaryotes are generally much smaller than eukaryotic cells.
• DNA organization: prokaryotes usually have a single circular chromosome; eukaryotes have multiple linear chromosomes in the nucleus.
• Cell wall: most bacteria have a cell wall made of peptidoglycan (a molecule unique to bacteria); eukaryotic cell walls (when present, as in fungi and plants) are made of different materials (chitin, cellulose); human cells have no cell wall.
• Ribosomes: both have ribosomes (for protein synthesis), but prokaryotic ribosomes are a different size than eukaryotic ones — a difference some antibiotics exploit.
• Reproduction: prokaryotes reproduce by simple binary fission (splitting in two); eukaryotes use mitosis (and meiosis).

Why this matters for antibiotics. The differences between bacterial (prokaryotic) and human (eukaryotic) cells are what make antibiotics possible: many antibiotics attack structures bacteria have but human cells lack — especially the peptidoglycan cell wall and the distinct bacterial ribosomes. This lets the drug harm bacteria while sparing human cells — the principle of selective toxicity. It also explains why antibiotics don't work on viruses (no such structures) and why targeting fungi or protozoa (eukaryotes like us) is trickier.

How It Works

The classification and its consequence:

Prokaryotes (bacteria, archaea): no nucleus/organelles, peptidoglycan wall (bacteria), circular DNA, distinct ribosomes, binary fission
Eukaryotes (fungi, protozoa, humans): true nucleus + organelles, linear DNA
Antibiotics exploit prokaryote-specific structures (cell wall, ribosomes) → selective toxicity (harm bacteria, spare humans)

Important Relationships and Comparisons

High-Yield Pre-Nursing Connections

Selective toxicity — the reason antibiotics can kill bacteria without harming us — depends on prokaryote–eukaryote differences (targeting the peptidoglycan wall or bacterial ribosomes). This explains why antibiotics are safe for humans yet lethal to bacteria, and why antifungal/antiprotozoal drugs (targeting eukaryotes) can have more side effects. Understanding these differences underlies how antimicrobials work and why they're chosen for specific pathogens.

Common Confusions

• Prokaryote vs eukaryote = no nucleus vs true nucleus (plus organelles).
• Bacteria and archaea are prokaryotes; fungi and protozoa are eukaryotes.
• Peptidoglycan is unique to bacteria — a key antibiotic target.
• Both have ribosomes, but different sizes (another antibiotic target).

Memory Aids

• "Prokaryote = PRO = no nucleus (primitive/before nucleus)."
• "Eukaryote = EU = a true (good) nucleus."
• "Peptidoglycan = bacteria only = antibiotic bullseye."

Quick Recap

• Prokaryotes (bacteria, archaea): no nucleus or membrane-bound organelles, usually circular DNA, peptidoglycan wall (bacteria), distinct ribosomes, reproduce by binary fission.
• Eukaryotes (fungi, protozoa, humans): true nucleus + organelles, linear chromosomes.
• These differences enable selective toxicity — antibiotics target bacteria-specific structures (cell wall, ribosomes) and spare human cells.
• This is why antibiotics work on bacteria but not viruses, and why antifungal/antiprotozoal drugs are harder to design safely.

Key terms

Key terms are emphasized and defined within the main notes.

Important formulas or processes

See the formulas, procedures, and process blocks in the main notes where applicable.

Common mistakes

See the labeled common-mistake callouts in the main notes where present.